Table 1.
Type | Conclusion (References) |
---|---|
Direct | Patients with OSAHS have early signs of AS.45,61 |
OSA treatment significantly improves early signs of AS.46 | |
There was a significant relationship between OSAHS severity and coronary atherosclerotic plaque volume.47 | |
Coronary heart disease incidence is higher in patients with OSAHS than in non-OSAHS individuals.48,49 | |
OSAHS contributes to ischemic stroke development.50–52 | |
OSAHS induces endothelial diastolic dysfunction.55 | |
OSAHS directly affects the vascular endothelium by promoting inflammation and oxidative stress while decreasing NO availability and repair capacity.56 | |
OSAHS induces EC apoptosis.57 | |
OSAHS changes EPC volume, suggesting EC damage.59,60 | |
Indirect | OSAHS promotes hypertension occurrence.67–69 |
OSAHS promotes obesity occurrence.17,70 | |
OSAHS promotes dyslipidemia occurrence.40,145,146 | |
OSAHS is associated with an increased risk of diabetes.76,77,154 |
Abbreviations: OSAHS, Obstructive sleep apnea–hypopnea syndrome; AS, Atherosclerosis; EPC, Endothelial progenitor cell; EC, Epithelial cell.